First Immune Therapy Drug Approved for Lung Cancer

March 4, 2015 10:49 PM

3 0

The Food and Drug Administration has okayed the first immune therapy drug for lung cancer.

The drug, called Opdivo, has shown good results against melanoma. Tests have shown it can work against squamous non-small cell lung cancer — one of several types of the No. 1 cancer killer.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page